62nd Annual William J. Holloway Infectious Disease Symposium

62nd Annual William J. Holloway Infectious Disease Symposium

Wednesday, May 7, 2025; 9:15am - 4:15pm EST

In Person: ChristianaCare Ammon Center
4755 Ogletown-Stanton Rd, Newark, DE 19718

Virtual Option (first come basis, limited spots available)
Zoom Videoconferencing

Registration is required. No late registrations will be accepted!

Registration deadline: April 30, 2025

Overview

The Annual William J. Holloway Infectious Disease Symposium continues its rich tradition of addressing topics of local and global significance of providers practicing medicine today.
 

Target Audience

This activity is intended for primary care physicians, specialty physicians, pharmacists, residents, medical students, physician assistants, nurses, and nurse practitioners.

Statement of Need

Lack of knowledge is present regarding changing resistance in infections, and options to treat. Specific to bronchiectasis is an expected knowledge of the condition but failure in clinical practice to incorporate knowledge to prevent and treat exacerbations. Knowledge of, and failure to incorporate access to Pre-exposure HIV treatment is one aspect of HIV expected to be covered.

Educational Objectives

Upon completion of this activity learners should be able to:

1. Discuss how to select antibiotics for drug resistant infections.
2. Discuss how to diagnose and treat bronchiectasis, and treat infectious exacerbations.
3. Discuss prophylactic use of antiviral medications for HIV, and treatment of HIV. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and Christiana Care. The Medical Society of Delaware is accredited by the ACCME to provide continuing medical education for physicians.

It is the policy of the Medical Society of Delaware (MSD) to comply with the ACCME Standards for Commercial Support of Continuing Medical Education (CME). In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations.

Joint providership of CME by MSD in no way implies endorsement of any product or service. 

This activity is not supported by commercial funding.


 

Credit Designation Statement

The Medical Society of Delaware designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity session enables the participant to earn up to 5.75 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.  Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

Upon successful completion of this course, the Medical Society of Delaware (MSD) will submit your completion data to ABIM via ACCME’s Program and Activity Reporting System (PARS) for MOC points.
 

Faculty and Disclosures

In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 24 months) with commercial interests/ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.

The following is a list of the faculty, along with any information they have disclosed regarding their relevant financial relationships.

Chad Duffalo, MD (Planner, Activity Director) - has no relevant financial relationship(s) with ineligible companies to disclose
David M. Cohen, MD (Planner, Moderator) - has no relevant financial relationship(s) with ineligible companies to disclose
Amy Minsker (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Erica Wilson, BSHS (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Clint Joseph Borja, PharmD, BCIDP (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Marci Drees, MD (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Nicole Harrington, PharmD (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Lynn Schaeffer, BS (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Omar Khan MD. MHS, FAAFP (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
John F. Reinhardt, MD (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose

Ali S. Khan MD, MPH, MBA (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose

Anne E. O'Donnell, MD (Speaker) - received grants/research (Georgetwon University) support for PI on clinical trials from Insmed, AN2, Armata, Boehringer Ingelheim, Zambon, Paratek, Renovian; received consulting for scientific advising from Insmed, Zambon, and Boehringer Ingelheim - All of the relevant financial relationships listed for this individual have been mitigated

Karlee Elizabeth Grudi (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose

Lisa Y Armitige, MD, PhD, FIDSA (Speaker) - consultant fee received from Oak Therapeutics, Inc. (NIH Small Business Innovation Rearch Grant) - All of the relevant financial relationships listed for this individual have been mitigated

Pranita D. Tamma, MD, MHS (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Valerie Lim (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Vinay Gheyi, MBBS, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
William P. Mazur, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose

Disclaimer

All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this educational activity. No single reference or service can take the place of medical training, education and experience. This educational event does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a health care provider.

Technical Requirements

This activity is best experienced using the most current browser of Firefox, Chrome, Safari, or Microsoft Edge. Avoid using public or hospital Wi-Fi when accessing your account. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.

Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.